A Study to Assess Placement and Confirmation of Peripheral Inserted Central Catheters Tip Position Using a New Electrocardiographic Method (SHERLOCK 3CG)

September 11, 2014 updated by: Centre Leon Berard

An Observational, Prospective, Single-center Study of Placement and Confirmation of Peripheral Inserted Central Catheters Tip Position Using a New Electrocardiographic Method

This is a prospective, single center, observational study. Patients who require a Peripheral Inserted Central Catheters (PICC) will constitute the study population.

The purpose of the study is to determine whether Sherlock 3CG, is adequate means for the total placement of PICC and confirmation of tip of PICC placement and if this method can be conducted safely and efficiently.

Patients will be included during a 6-month period as well as they are ambulatory or hospitalized. The patient's routine care will not be modified and only PICC will be assessed in the present study.

PICC placement will be performed using the Site Rite guidance and tip position will be confirmed using the Sherlock 3CG.

The procedure is the same as the routine habits of the operator (nurse or anesthesiologist); the vascular access team already uses the previous device for CVC placement.

Patients won't be followed up in the study.

Study Overview

Status

Completed

Conditions

Detailed Description

Our current Central Venous Catheter placement protocol for PICC includes the resort to UltraSonography (US) and requires fluoroscopy and plain radiographies throughout the PICC insertion and until the confirmation of best placement.

This verification is mandatory to avoid the risks, delays and costs of repositioning the tip, but obtaining a fluoroscopy and plain radiographies in operating rooms can be time consuming and exposes the patient, nurses and physicians to radiations.

The use of endocavitary electrocardiogram for tip position confirmation has been developed since 1985 and is now recognized as an alternative method. It has been recognized as the best technique in other indications, such as hemodialysis. It helps to position PICC tip in proximity to the cavoatrial junction. In Europe, Italian and German teams already use this new method.

A new ultrasound machine offering external sensors and Endocavitary ECG guide is now available (Site Rite and Sherlock 3CG - Tip Confirmation System), which allows the installation and proper placement in the same operation. This Sherlock 3CG TCS has already been approved by the Food and Drug Administration in the US and is indicated for PICC tip placement confirmation in adult patients.

This new ECG guidance method will allow the PICC insertion without any radiation in the operating room.

For the moment, according to the local recommendations, French patients will have to continue to perform one post-procedural X-ray to confirm tip position. This exam will be performed in a dedicated room of the radiology unit. But guidance and confirmation of CVC placement only by ECG may provide a faster means of confirmation and eliminates radiation exposure to the patients, nurses and anesthesiologists.

In addition, it would eliminate the costs associated with confirmatory chest X-ray (exam costs and time consumption).

Study Type

Observational

Enrollment (Actual)

571

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France, 69008
        • Centre Léon Bérard

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients will be included as well as they are ambulatory or hospitalized in Centre Leon Berard.

Description

Inclusion Criteria:

  • 18 years-old patient or older,
  • Patient requiring PICC placement in the vascular access unit,
  • Patient able to read and understand the French language,
  • Patient affiliated with a social security system.

Exclusion Criteria:

  • Any contraindication to PICC insertion,
  • Patient unable to lie in the supine position
  • Patient with a Body Mass Index > 40
  • Any medical condition that could change the normal presentation of the P-wave such as arrhythmia, atrial flutter, pace maker with permanent stimulation…

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
PICC placement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficacy of PICC placement using the Sherlock 3CG
Time Frame: During the procedure (Day 0)
Success rate of PICC placement (no need to use radiation or fluoroscopy before the end of the procedure)
During the procedure (Day 0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess the number of punctures in brachial site
Time Frame: During the procedure (Day 0)
Efficacy of needle guide
During the procedure (Day 0)
Assess the unique punction rate
Time Frame: During the procedure (Day 0)
During the procedure (Day 0)
Assess the number of repositions after procedure closed
Time Frame: During the procedure (Day 0)
During the procedure (Day 0)
Assess pain
Time Frame: During the procedure (Day 0)
By means of a Verbal Numeric Scale
During the procedure (Day 0)
Assess acute complications rate
Time Frame: During the procedure (Day 0)
Hemothorax, arterial puncture, etc.
During the procedure (Day 0)
Assess the percentage of patients requiring fluoroscopy
Time Frame: During the procedure (Day 0)
During the procedure (Day 0)
Assess the final radiation rate
Time Frame: During the procedure (Day 0)
When applicable
During the procedure (Day 0)
Assess the percentage of patients with good placement on the X-Ray
Time Frame: During the procedure (Day 0)
During the procedure (Day 0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (ACTUAL)

April 1, 2014

Study Completion (ACTUAL)

April 1, 2014

Study Registration Dates

First Submitted

October 22, 2013

First Submitted That Met QC Criteria

October 22, 2013

First Posted (ESTIMATE)

October 25, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

September 12, 2014

Last Update Submitted That Met QC Criteria

September 11, 2014

Last Verified

September 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • SHERLOCK 3CG
  • 1626789 (OTHER: CNIL number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on PICC placement with Sherlock 3CG

3
Subscribe